The Natural History of CMV-Related Hearing Loss and the Feasibility of CMV Screening as Adjunct to Hearing Screening in Newborns

Study ID
STU 072010-124

Cancer Related
No

Healthy Volunteers
No

Study Sites

  • Children's Medical Center-Dallas
  • Parkland Health & Hospital System

Contact
Lizette Torres
214-456-2585
lizette.torres@utsouthwestern.edu

Principal Investigator
Audra Stewart

Summary

The natural History of CMV-Related Hearing Loss and the Feasibility of CMV Screening as adjunct to Hearing Screening in newborns
approximately 100,000 newborns will be screened for CMV infection. all infants who test positive for CMV will be enrolled in an audiometric follow-up arm. The accuracy of two diagnostic methodologies for newvorn CMV screening will be compared. The study consists of three phases. Phase i is startup and development of study mehodologies and procedures. Phase ii is the collection of pilot data at each site. Phase iii is the initiation of the full study.

Participant Eligibility

All infants of both genders and all ethnicities who are born at Parkland Memorial Hospital (PMH) will be eligible for newborn CMV screening after obtaining informed consent from the mother.